Loomis, Sayles & Company’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-379,033
Closed -$19.8M 818
2019
Q4
$19.8M Sell
379,033
-1,215
-0.3% -$55.6K 0.03% 216
2019
Q3
$15.2M Buy
380,248
+43,598
+13% +$2.01M 0.03% 257
2019
Q2
$16.1M Sell
336,650
-98,532
-23% -$3.97M 0.03% 243
2019
Q1
$23.9M Buy
435,182
+270,843
+165% +$12.9M 0.05% 175
2018
Q4
$5.99M Buy
164,339
+29,961
+22% +$1.23M 0.01% 396
2018
Q3
$6.67M Buy
+134,378
New +$6.84M 0.01% 446

Other funds holding ZGNX

Loomis, Sayles & Company's ZGNX Position: Q1 2020 in Review

Loomis, Sayles & Company sold out of Zogenix, Inc. (ZGNX) in Q1 2020, closing a stake of 379,033 shares — an estimated $19.8M sold.

Loomis, Sayles & Company first reported a position in ZGNX in Q3 2018 and held it in 6 quarters. The position peaked at $23.9M in Q1 2019. 163 funds tracked by Wall St. Rank hold ZGNX as of Q1 2020.

  • Loomis, Sayles & Company reported no remaining Zogenix, Inc. position as of Q1 2020 after selling out during the quarter.
  • Loomis, Sayles & Company sold 379,033 Zogenix, Inc. shares in Q1 2020, an estimated $19.8M.
  • Loomis, Sayles & Company first reported a position in Zogenix, Inc. in Q3 2018 and held it in 6 quarters.
  • Loomis, Sayles & Company's Zogenix, Inc. position peaked at $23.9M in Q1 2019.
  • 163 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2020.

Based on Loomis, Sayles & Company's 13F filing for Q1 2020, filed 15 May 2020.